COMy 2019

3:58
CyborD-DARA combination in first-line treatment for multiple myeloma
Michael O’Dwyer
2:18
Treating younger MM patients: finding the optimal induction regimen
Joan Blade
0:39
Genomic advances in MM disease biology
Irene Ghobrial
2:15
Update on WM biology and therapy
Steven Treon
3:12
The use of imaging to determine MRD
Elena Zamagni
0:54
Immune-mediated mechanisms of progression in MGUS and smouldering myeloma
Irene Ghobrial
1:47
Risk stratification of MGUS
Vincent Rajikumar
2:49
The case for IMiDs in relapsed MM
Meral Beksac
3:36
Daratumumab practical considerations in MM
Torben Plesner
1:23
AL amyloidosis: an update from Dr Merlini
Giampaolo Merlini
2:37
CAR-T cells for myeloma: experience from China
He Huang
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals